11/28/2016
FDA release on Intrarosa approval omits important conflict of interest
10/18/2016
Steroid treatment for preterm infants: NIH release skimps on data and study limitations
9/30/2016
FDA release offers inadequate presentation of auto-inflammatory drug approval
7/6/2016
FDA release on hepatitis C drug informs on harms, benefits but is light on evidence
5/26/2016
Once again, NIH release on blood pressure targets lacks info on absolute benefits, potential harms
5/24/2016
FDA PR release on bladder cancer drug skirts lack of long-term survival data
5/10/2016
FDA release on drug for treating Parkinson’s psychosis lacks some key details
4/14/2016
NIH release delivers most of the goods on long-term heart surgery outcomes
3/29/2016
Release on federally funded anti-smoking campaign describes impressive reach but unclear on cost
3/2/2016
Exemplary explanation of study comparing diabetic macular edema treatments
